| Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond C Marchiò, L Annaratone, A Marques, L Casorzo, E Berrino, A Sapino Seminars in cancer biology 72, 123-135, 2021 | 227 | 2021 |
| Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial A Sartore-Bianchi, F Pietrantonio, S Lonardi, B Mussolin, F Rua, ... Nature Medicine 28 (8), 1612-1618, 2022 | 120 | 2022 |
| Basic principles of biobanking: from biological samples to precision medicine for patients L Annaratone, G De Palma, G Bonizzi, A Sapino, G Botti, E Berrino, ... Virchows Archiv 479, 233-246, 2021 | 93 | 2021 |
| The multifaceted nature of tumor microenvironment in breast carcinomas L Annaratone, E Cascardi, E Vissio, I Sarotto, E Chmielik, A Sapino, ... Pathobiology 87 (2), 125-142, 2020 | 67 | 2020 |
| Next-generation sequencing approaches for the identification of pathognomonic fusion transcripts in sarcomas: the experience of the Italian ACC sarcoma working group D Racanelli, M Brenca, D Baldazzi, F Goeman, B Casini, B De Angelis, ... Frontiers in Oncology 10, 489, 2020 | 46 | 2020 |
| Acid-free glyoxal as a substitute of formalin for structural and molecular preservation in tissue samples G Bussolati, L Annaratone, E Berrino, U Miglio, M Panero, M Cupo, ... PLoS One 12 (8), e0182965, 2017 | 37 | 2017 |
| The expression of LINE1‐MET chimeric transcript identifies a subgroup of aggressive breast cancers U Miglio, E Berrino, M Panero, G Ferrero, L Coscujuela Tarrero, V Miano, ... International Journal of Cancer 143 (11), 2838-2848, 2018 | 34 | 2018 |
| Cold formalin fixation guarantees DNA integrity in formalin fixed paraffin embedded tissues: premises for a better quality of diagnostic and experimental pathology with a … E Berrino, L Annaratone, U Miglio, E Maldi, C Piccinelli, E Peano, ... Frontiers in oncology 10, 173, 2020 | 29 | 2020 |
| Establishment and characterization of a new intrahepatic cholangiocarcinoma cell line resistant to gemcitabine C Varamo, C Peraldo-Neia, P Ostano, M Basiricò, C Raggi, P Bernabei, ... Cancers 11 (4), 519, 2019 | 29 | 2019 |
| The dilemma of HER2 double-equivocal breast carcinomas: genomic profiling and implications for treatment C Marchiò, P Dell’Orto, L Annaratone, FC Geyer, T Venesio, E Berrino, ... The American journal of surgical pathology 42 (9), 1190-1200, 2018 | 25 | 2018 |
| Unusual patterns of HER2 expression in breast cancer: Insights and perspectives D Grassini, E Cascardi, I Sarotto, L Annaratone, A Sapino, E Berrino, ... Pathobiology 89 (5), 278-296, 2022 | 24 | 2022 |
| Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas E Berrino, L Annaratone, SE Bellomo, G Ferrero, A Gagliardi, A Bragoni, ... Genome Medicine 14 (1), 98, 2022 | 23 | 2022 |
| COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance M Simonetti, N Zhang, L Harbers, MG Milia, S Brossa, TT Huong Nguyen, ... Nature Communications 12 (1), 3903, 2021 | 23 | 2021 |
| Oxidative DNA damage induces hypomethylation in a compromised base excision repair colorectal tumourigenesis D Furlan, D Trapani, E Berrino, C Debernardi, M Panero, L Libera, ... British journal of cancer 116 (6), 793-801, 2017 | 23 | 2017 |
| Pazopanib and trametinib as a synergistic strategy against osteosarcoma: Preclinical activity and molecular insights G Chiabotto, G Grignani, M Todorovic, V Martin, ML Centomo, E Prola, ... Cancers 12 (6), 1519, 2020 | 18 | 2020 |
| High BRAF variant allele frequencies are associated with distinct pathological features and responsiveness to target therapy in melanoma patients E Berrino, A Balsamo, A Pisacane, S Gallo, P Becco, U Miglio, D Caravelli, ... ESMO open 6 (3), 100133, 2021 | 17 | 2021 |
| Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs) A Pisacane, E Cascardi, E Berrino, A Polidori, I Sarotto, L Casorzo, ... Virchows Archiv 482 (3), 463-475, 2023 | 16 | 2023 |
| Alleanza Contro il Cancro (ACC) Pathology and Biobanking Working Group. Basic principles of biobanking: from biological samples to precision medicine for patients L Annaratone, G De Palma, G Bonizzi, A Sapino, G Botti, E Berrino, ... Virchows Arch 479 (2), 233-46, 2021 | 16 | 2021 |
| Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance V Amodio, S Lamba, R Chilà, CM Cattaneo, B Mussolin, G Corti, G Rospo, ... Cancer Cell 41 (1), 196-209. e5, 2023 | 15 | 2023 |
| Castration-induced downregulation of SPARC in stromal cells drives neuroendocrine differentiation of prostate cancer C Enriquez, V Cancila, R Ferri, R Sulsenti, I Fischetti, M Milani, P Ostano, ... Cancer Research 81 (16), 4257-4274, 2021 | 15 | 2021 |
